Psa Drugs LLP
About Psa Drugs LLP
Data last updated:
Psa Drugs LLP is a limited liability partnership (LLP) based in Kolkata, West Bengal, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 31 May 2017 and has been in existence for over 9 years.
The LLP is registered with the Registrar of Companies (ROC), Kolkata, under LLPIN AAJ-5711. Its GSTIN is 19AAUFP3031E1Z5 (West Bengal).
The LLP has a total obligation of contribution of ₹1 Lakh. It is led by designated partners Pradip Sachan and Shalini Sachan.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at 8 Da Mani Tower 31/41 Binova Bhave Road Sahapur, Kolkata, West Bengal, India – 700038.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address8 Da Mani Tower 31/41 Binova Bhave Road Sahapur, Kolkata, West Bengal, India – 700038
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Psa Drugs LLP FY 2025 filings available
Financial Statement Summary of Psa Drugs LLP
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Income | •••• | •••• | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• | •••• | •••• |
| Profit After Tax | •••• | •••• | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• | •••• | •••• |
| Assets and Liabilities | |||||
| Partners' Contribution | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Psa Drugs LLP
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Psa Drugs are in the company report.
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Designated Partners of Psa Drugs LLP
Psa Drugs has 2 designated partners on record. No former designated partners are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pradip Sachan Also directs: Lunaris Pharma Private Limited, Aman Drugs Private Limited, Avenue Pharma Private Limited and 1 more | Designated Partner | 31 May 2017 | 9 Years 4 Months | Current |
| Shalini Sachan | Designated Partner | 31 May 2017 | 9 Years 4 Months | Current |
Charges & Borrowings of Psa Drugs LLP
Psa Drugs LLP does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Psa Drugs LLP
Employment history and EPFO contributions of people linked to Psa Drugs.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Psa Drugs LLP
Psa Drugs LLP has 2 designated partner changes on record since 2017: 2 appointments. The latest: Pradip Sachan was appointed as Designated Partner on 31 May 2017.
Credit Ratings, Litigation & Regulatory Alerts for Psa Drugs LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Psa Drugs LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Psa Drugs LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Psa Drugs LLP
Psa Drugs has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AAUFP3031E1Z5 | West Bengal | Active | 26 Mar 2021 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Psa Drugs LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Psa Drugs LLP
Psa Drugs is an active limited liability partnership based in Kolkata, West Bengal, India. The LLP works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 31 May 2017 (9+ years old) and is registered under LLPIN AAJ-5711.
Psa Drugs has 2 current designated partners:
- Pradip Sachan - Designated Partner
- Shalini Sachan - Designated Partner
The GSTIN of Psa Drugs is 19AAUFP3031E1Z5, registered in West Bengal.
The LLPIN (Limited Liability Partnership Identification Number) of Psa Drugs is AAJ-5711. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Psa Drugs was incorporated on 31 May 2017, making it 9+ years old. It is registered with the Registrar of Companies, Kolkata.
Pradip Sachan was appointed as Designated Partner on 31 May 2017. Shalini Sachan was appointed as Designated Partner on 31 May 2017.
The registered office of Psa Drugs is at 8 Da Mani Tower 3141 Binova Bhave Road Sahapur, Kolkata, West Bengal, India – 700038.
The total obligation of contribution is ₹1 Lakh.
Psa Drugs operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Psa Drugs can be reached at its registered office: 8 Da Mani Tower 3141 Binova Bhave Road Sahapur, Kolkata, West Bengal, India – 700038.